| DB ID | MyCo_2393 |
| Title | Galactomannan detection as a tool for the diagnosis and management of cardiac aspergillosis in 2 immunocompetent patients |
| Year | 2008 |
| PMID | 18945209 |
| Fungal Diseases involved | Cardiac aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | None |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Spain |
| Cohort | Serum galactomannan antigen detection was used for the diagnosis and follow-up of cardiac aspergillosis after surgery in 2 nonneutropenic patients. The first patient was a 13-year-old nonneutropenic boy with congenital heart disease that included transposition of the great arteries, ventricular septal defect, and pulmonary stenosis. The second patient was a 12-year-old nonneutropenic boy with pulmonary valve atresia and ventricular septal defect. Sur- gery was performed at 3 years of age (ventricular septal defect closure and right ventricle–pulmonary artery conduit). |
| Cohort No. | 2 |
| Age Group | Dec-13 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | ELISA |
| Technique | Immunoassay |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA; Bio-Rad, Marnes la Coquette, France) |
| Assay Data | None |
| Validation Techniques used | FDA Approved -Platelia Aspergillus Ag ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
